Family Legacy Financial Solutions, LLC Biocryst Pharmaceuticals Inc Transaction History
Family Legacy Financial Solutions, LLC
- $118 Billion
- Q2 2025
A detailed history of Family Legacy Financial Solutions, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Family Legacy Financial Solutions, LLC holds 8,026 shares of BCRX stock, worth $69,826. This represents 0.06% of its overall portfolio holdings.
Number of Shares
8,026Holding current value
$69,826% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
295Shares Held
181MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$174 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$77.7 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$75.7 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$68 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.62B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...